Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1441-1450 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|June 3, 2015
Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublinesMing Chen, Hong Huang, Haojie He, et al.
Cancer Science|February 11, 2026
The Sparing Effect of Multibeam Ultra-High Dose-Rate Irradiation on Intestinal Tissue in MiceWeiping Wang, Ziqi Zhou, Peng Wang, et al.
Cancer Science|February 13, 2026
Mitochondrial Transfer in the Tumor MicroenvironmentRyo Omae, Takamasa Ishino, Yosuke Togashi
Cancer Science|February 17, 2026
The Overlooked Autoantibody Repertoire: Exploring the Biomarker Potential of Downregulated Autoantibodies in NSCLCYihao Liang, Hanke Ma, Wenke Sun, et al.
Cancer Science|February 2, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With AtezolizumabAtsuto Mouri, Hiroshi Kagamu, Koji Tamada, et al.
Cancer Science|January 30, 2026
Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical OutcomesKinnosuke Matsumoto, Yujiro Naito, Takayuki Shiroyama, et al.
Cancer Science|January 27, 2026
IAP Antagonists Selectively Eliminate Therapy-Induced Senescent Cancer Cells via TNFα-Independent ApoptosisHiroaki Ochiiwa, Takeshi Wakasa, Yuki Kataoka, et al.
Cancer Science|December 29, 2025
Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in JapanTetsuya Mori, Akiko Kada, Tomoo Osumi, et al.
Cancer Science|April 18, 2020
Pharmacological targeting of natural killer cells for cancer immunotherapyKiho Miyazato, Yoshihiro Hayakawa
Cancer Science|February 25, 2023
Sclerostin blockade promotes bone metastases of Wnt-responsive breast cancer cellsToru Hiraga, Kanji Horibe, Masanori Koide, et al.
Pageof 695

Showing results (1441-1450 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|June 3, 2015
Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublinesMing Chen, Hong Huang, Haojie He, et al.
Cancer Science|February 11, 2026
The Sparing Effect of Multibeam Ultra-High Dose-Rate Irradiation on Intestinal Tissue in MiceWeiping Wang, Ziqi Zhou, Peng Wang, et al.
Cancer Science|February 13, 2026
Mitochondrial Transfer in the Tumor MicroenvironmentRyo Omae, Takamasa Ishino, Yosuke Togashi
Cancer Science|February 17, 2026
The Overlooked Autoantibody Repertoire: Exploring the Biomarker Potential of Downregulated Autoantibodies in NSCLCYihao Liang, Hanke Ma, Wenke Sun, et al.
Cancer Science|February 2, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With AtezolizumabAtsuto Mouri, Hiroshi Kagamu, Koji Tamada, et al.
Cancer Science|January 30, 2026
Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical OutcomesKinnosuke Matsumoto, Yujiro Naito, Takayuki Shiroyama, et al.
Cancer Science|January 27, 2026
IAP Antagonists Selectively Eliminate Therapy-Induced Senescent Cancer Cells via TNFα-Independent ApoptosisHiroaki Ochiiwa, Takeshi Wakasa, Yuki Kataoka, et al.
Cancer Science|December 29, 2025
Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in JapanTetsuya Mori, Akiko Kada, Tomoo Osumi, et al.
Cancer Science|April 18, 2020
Pharmacological targeting of natural killer cells for cancer immunotherapyKiho Miyazato, Yoshihiro Hayakawa
Cancer Science|February 25, 2023
Sclerostin blockade promotes bone metastases of Wnt-responsive breast cancer cellsToru Hiraga, Kanji Horibe, Masanori Koide, et al.
Pageof 695